/api/archive/snapshots/13924b03d72bbc36c06e7e0debbe7f8ac8ff90fc9b7c2f4ded9bc74576077a62/page.html
View dossier →Jonah Dallas Yakel alias The Chronicity Chaser
Facebook · 100053956045238
Practice location
11791 W 112TH ST
OVERLAND PARK, KS 66210
Funnel-first framing that runs on persuasion, light on published evidence.
- Of 8 health claims, 4 run counter to or conflict with the published evidence, and 4 were not independently checked.
- Primary persuasion tactic: Free discovery call funnel.
- Stated credentials look inflated relative to the advice given.
- Profits from the products and labs they recommend, with no clear disclosure.
- Gives advice beyond what their license covers.
Here we have the classic integrative clinic flex: stack the scary conditions, add a shiny ranking badge, and invite the worried viewer into a free discovery call. No need for a potion shelf on this clip when the intake form is already the product.
High grift signals
Score breakdown
Direct answer
Jonah Dallas Yakel is licensed in Kansas as a chiropractor (DC), not as an MD or DO, and Kansas's chiropractic scope statute (K.S.A. 65-2912(a)(6) (used by analogy for non-physician licensees under KSBHA)) limits that license to musculoskeletal care, not the diagnosis or treatment of systemic disease. Even so, they advertise diagnosing or treating Lyme, long COVID, autoimmunity, chronic mold illness management, and Lyme disease management, conditions that belong with infectious-disease physicians, rheumatologists, and allergy and immunology specialists. Those same pages route patients toward paid programs that Jonah Dallas Yakel profits from.
Key findings
- Sales Funnel Motive: This is a classic top-of-funnel booking CTA. It turns fear about complex chronic illness into a lead capture event, likely before any clear diagnosis or treatment rationale is disclosed.see section ↓
- Claim "mold": not supported by peer-reviewed evidence.see section ↓
- Claim "Lyme": mixed in the medical literature.see section ↓
- NPI registry confirms Jonah Yakel as Chiropractor (DC) in Kansas (NPI 1619145026).see section ↓
- Jonah Dallas Yakel shows credential inflation relative to stated vs likely credentials.see section ↓
- Dr Jonah Dallas Yakel is marketed with a doctor title, but reviewed credentials indicate Chiropractor (DC) rather than an MD/DO physician license.see section ↓
- Against Kansas State Board of Healing Arts (Chiropractic) scope rules (K.S.A. 65-2912(a)(6) (used by analogy for non-physician licensees under KSBHA)), these advertised activities appear outside Jonah Dallas Yakel's license (including conditions they merely list as ones they treat): Lyme, long…see section ↓
- 13 of 13 advertised activities fall outside permitted Chiropractor scope in KS.see section ↓
Claims & evidence
13 advertised conditions or treatments fall outside their license scope. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Lyme.
Lyme
- Supports
- Because the influencer’s claim is only the single word “Lyme,” there is no specific, testable assertion (for example, about diagnosis, chronic infection, specific treatments, or vaccines). However, there is strong high‑quality evidence and major guidelines describing Lyme disease as a well‑characterized tick‑borne bacterial infection, its diagnostic approach, and short‑course antibiotic treatment as effective for typical disease. Multiple evidence‑based guidelines (IDSA/AAN/ACR 2020, national guideline summaries) endorse: (1) clinical diagnosis and prompt antibiotic therapy for typical erythema migrans without needing laboratory confirmation; (2) two‑tier serologic testing (screening EIA followed by confirmatory immunoblot) as the standard laboratory method for most other presentations; and (3) defined, relatively short courses of antibiotics (generally 10–28 days) depending on the clinical manifestation, with no evidence that longer courses improve outcomes.[1][2][8][11][16][18] High‑quality European guidelines for neuroborreliosis similarly support that early neuroborreliosis is effectively treated with a 14‑day antibiotic course and that combination or prolonged antibiotic regimens lack valid supporting data.[5] Recent PTLDS guidelines and systematic reviews conclude that in patients with persistent symptoms after appropriate Lyme treatment, additional prolonged or repeated antibiotic courses do not improve quality of life, fatigue, depression, or cognition and are therefore not recommended.[4][5] Major public health authorities and guideline panels (e.g., CDC, IDSA, NICE/NCBI Bookshelf) consistently state that Lyme disease is a recognized infectious disease caused by Borrelia species, primarily transmitted by Ixodes ticks, and that timely, guideline‑based antibiotic therapy is effective for the majority of patients.[7][8][11][18]
- Contradicts
- Because the influencer’s claim is not specific, areas of contradiction or weak evidence mainly concern common controversial narratives about “chronic Lyme” or indefinite antibiotic therapy rather than the existence of Lyme disease itself. High‑quality guidelines and systematic reviews explicitly report that prolonged or repeated antibiotic courses beyond standard durations for post‑treatment persistent symptoms (PTLDS) do not show clinically meaningful benefit in randomized trials or systematic evaluations, and therefore such practices are not recommended.[4][5][17] European neuroborreliosis guidelines note that there are no valid study data supporting combination antibiotic treatments or extended regimens beyond guideline‑specified durations.[5] PTLDS guidance likewise concludes that persistent symptoms after adequate treatment are not attributable to ongoing active infection and that management should focus on multidisciplinary supportive care rather than further antibiotics.[4][5] Major guidelines also emphasize that many patients labeled with “chronic Lyme” lack objective evidence of prior Lyme infection and that Lyme disease is the correct diagnosis for only a minority of patients in whom it is suspected, highlighting diagnostic over‑attribution in some clinical and influencer narratives.[15] In addition, authoritative sources advise against unvalidated diagnostic methods (e.g., nonstandard serologic assays, urine antigen tests, tick testing) and against assuming Lyme disease in the face of negative, properly performed serologic testing with long‑standing symptoms, which contradicts claims that standard tests are broadly unreliable and that Lyme is almost always occult.[8][13][18]
- Mainstream view
- Mainstream medical and scientific consensus is that Lyme disease is a well‑defined zoonotic infection caused by Borrelia burgdorferi sensu lato (and related species), transmitted primarily by Ixodes ticks, with characteristic early manifestations (particularly erythema migrans) and well‑described neurologic, cardiac, and rheumatologic complications in some patients.[1][9][11][18] Diagnosis is based on clinical assessment plus epidemiologic exposure (especially for erythema migrans) and standardized two‑tier serologic testing for most other presentations, using validated assays and interpretive criteria.[8][11][18] Treatment consists of appropriately selected antibiotics (such as doxycycline, amoxicillin, cefuroxime, or IV ceftriaxone) for defined durations typically between 10 and 28 days, tailored to the specific syndrome (early localized disease, neuroborreliosis, arthritis, etc.), with strong evidence that these regimens are generally effective and that longer or repeated courses do not confer additional benefit.[1][5][6][16][18] Persistent or nonspecific symptoms after adequate treatment (PTLDS) are recognized but are not attributed to ongoing active infection; management focuses on rehabilitation and symptom‑directed, multidisciplinary care rather than further antibiotics.[4][5] Major guidelines and public health agencies do not support the concept of “chronic Lyme Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“If you are struggling with mold, Lyme, long COVID, autoimmunity, or any neurodegenerative disorder”
Rule: K.S.A. 65-2912(a)(6) (used by analogy for non-physician licensees under KSBHA)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure long COVID.
long COVID
- Supports
- The general claim that long COVID exists as a clinically recognized condition is strongly supported by multiple systematic reviews, meta-analyses and major guidelines from 2021–2026. Long COVID (also called post‑acute sequelae of SARS‑CoV‑2 infection, post‑COVID‑19 condition, or post‑COVID syndrome) is consistently described as persistent, relapsing, or newly developed symptoms following SARS‑CoV‑2 infection that last beyond the acute phase, typically at least 4 weeks and more often 3 months or longer. Multiple systematic reviews and meta-analyses document substantial global prevalence of persistent symptoms after COVID-19, often in the range of roughly 20–40% depending on definition, population, and follow‑up duration, supporting that long COVID represents a major post‑acute public health burden. [11] A comprehensive systematic scoping review of long COVID literature reports that many studies describe persistent fatigue, breathlessness, arthralgia, sleep difficulties, chest pain, and other multi‑system symptoms long after acute infection, including cutaneous, respiratory, cardiovascular, musculoskeletal, neurologic, mental health, and renal involvement, which supports the existence of a long‑term sequelae syndrome. [10] Living and conventional systematic reviews characterising long COVID conclude that it is a heterogeneous condition affecting both previously hospitalized and non‑hospitalized people, with prolonged fatigue, weakness, malaise, breathlessness, and concentration impairment lasting weeks to months. [12] A large systematic review and meta-analysis of post‑COVID syndrome prevalence defines post‑COVID syndrome as signs and symptoms developing during or after infection, continuing beyond 12 weeks and not explained by another diagnosis, and finds non‑trivial prevalence, reinforcing recognition of long COVID as a chronic sequela. [9] Similarly, systematic reviews of post‑acute sequelae in hospitalized patients, and of long-term sequelae over multi‑year follow‑up, confirm that many individuals experience persistent symptoms and organ-specific complications well beyond the initial illness, again supporting the reality of long COVID. High‑level guidance bodies explicitly define long COVID/post‑COVID condition. The World Health Organization consensus definition describes post‑COVID‑19 condition as continuation or development of new symptoms three months after initial infection, lasting at least two months and not explained by an alternative diagnosis, demonstrating formal international recognition. This definition is echoed and operationalized within recent global prevalence reviews. The UK’s NICE guidance and related patient‑facing summaries advise clinicians to consider long COVID when symptoms develop during or after COVID‑19 and continue for more than 12 weeks without an alternative explanation, operationalizing the concept into clinical practice. The National Academies of Sciences, Engineering and Medicine (NASEM) 2024 report similarly defines long COVID as an infection‑associated chronic condition after SARS‑CoV‑2 infection, present for at least three months, with continuous, relapsing‑remitting, or progressive disease affecting one or more organ systems, reinforcing its status as a recognized chronic disease state. Systematic reviews also support specific long COVID manifestations, such as pain syndromes and sleep disturbances. Meta‑analyses of long‑term post‑acute sequelae related to pain document that a subset of patients suffer pain and other symptoms for more than one month after initial onset or hospital discharge, fitting long COVID definitions. A global systematic review and meta‑analysis of long COVID insomnia and randomized controlled trial meta‑analyses of interventions for sleep disturbances in long COVID patients further support that sleep-related symptoms are common and clinically significant components of long COVID, and that targeted management strategies are being studied. Additionally, systematic reviews of specific post‑COVID conditions such as postural orthostatic tachycardia syndrome (POTS) show that dysautonomia syndromes can occur following COVID-19 as part of long COVID and often require pharmacologic treatment, again underscoring the clinical reality of long‑term sequelae. Overall, high‑quality evidence from systematic reviews, meta‑analyses and major guidelines strongly supports the existence of long COVID as a clinically important, heterogeneous, and sometimes chronic sequela of SARS‑CoV‑2 infection, with multi‑system manifestations and substantial prevalence, even though case definitions and exact prevalence estimates vary.
“If you are struggling with mold, Lyme, long COVID, autoimmunity, or any neurodegenerative disorder”
Rule: K.S.A. 65-2912(a)(6) (analogous scope limit)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure autoimmunity.
autoimmunity
- Supports
- The influencer’s claim is just the single word “autoimmunity,” with no explicit proposition (for example, that autoimmunity is always harmful, always curable, caused only by diet, etc. [22][23][24] ), so there is no specific claim that can be directly supported by the listed index papers. The index papers provided relate to hypertension management , clinical nutrition and parenteral/enteral feeding , nutrition in inflammatory bowel disease (which can include autoimmune forms of IBD) , methods for rating evidence quality , and several unrelated clinical trials on DNA sequencing in practice, analgesia, wound healing, and infectious disease treatment . [1][2][3][20] None of these papers present a core definitional or mechanistic claim about autoimmunity itself that would allow a direct “support” of any particular influencer assertion about autoimmunity. They show only that autoimmune phenomena may be relevant in specific diseases such as inflammatory bowel disease and AIDS-related infections, and that evidence grading and guideline-driven care are used in clinical research and practice, but they do not substantiate any standalone influencer claim about autoimmunity. [21]
- Contradicts
- Because the influencer’s claim is not specified beyond the word “autoimmunity,” there is no concrete proposition (for example, that autoimmunity is purely a lifestyle choice, universally reversible, or always misdiagnosed) that can be compared against the index papers. [22][23][24] The guideline-driven hypertension management paper focuses on cardiovascular risk factors and pharmacologic/nonpharmacologic blood pressure control, not on autoimmunity, and would contradict any implication that hypertension treatment is primarily an autoimmune issue. [1] The ASPEN-FELANPE and ESPEN nutrition guidelines focus on evidence-based nutrition care in critical illness and inflammatory bowel disease and do not assert that autoimmunity is the root cause of all disease or that simple nutritional changes universally cure autoimmune conditions. [2][3][21] The GRADE methodology paper demonstrates that mainstream medicine requires high-quality, precise evidence before strong clinical claims are accepted, which would contradict any sweeping, unqualified influencer statements about autoimmunity that lack such supporting data. [20] The remaining clinical trials (DNA sequencing in practice, tizanidine as an analgesic adjunct, platelet-rich fibrin for mucosal healing, and cryptosporidiosis treatment in AIDS) focus on distinct clinical problems and do not support extreme, generalized claims about autoimmunity as their unifying mechanism or cure.
- Mainstream view
- Mainstream medical and scientific positions hold that autoimmunity refers to immune responses directed against self-antigens, leading to a wide spectrum of autoimmune diseases, many of which are chronic and require long-term management rather than simple cures. [21][22][24] Autoimmunity is understood as multifactorial, involving genetic predisposition, immune regulation, environmental triggers, and in some cases nutritional status or gut-related factors, but it is not considered the single cause of all disease. Major guidelines in other areas, such as hypertension and clinical nutrition, illustrate that mainstream medicine treats autoimmunity as one among many important mechanisms in human disease, and uses structured frameworks like GRADE to evaluate evidence before adopting management strategies. [1][2][3][20][23] Inflammatory bowel disease guidelines, for example, acknowledge immune-mediated and inflammatory mechanisms but still emphasize a comprehensive approach combining pharmacologic, nutritional, and sometimes surgical management, rather than framing autoimmunity alone as the entire explanation or an easily reversible process. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“If you are struggling with mold, Lyme, long COVID, autoimmunity, or any neurodegenerative disorder”
Rule: K.S.A. 65-2912(a)(6) (analogous scope limit on treating ailments outside the act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure chronic mold illness management.
chronic mold illness management
- Supports
- No high-quality evidence in the provided index papers supports the standalone claim “mold” as a medical assertion. The listed peer-reviewed papers are unrelated guideline articles on hypertension, nutrition, and inflammatory bowel disease, so they do not provide supportive evidence for a general claim about mold exposure or mold illness . [1][3][4]
- Contradicts
- The claim is too vague to evaluate as written, and the provided index papers do not address mold at all; therefore they neither support nor meaningfully test it . In mainstream medical literature, indoor dampness and visible mold are associated with respiratory symptoms and asthma exacerbation, but broad claims that mold causes nonspecific systemic illness in most people are not established by major guidelines or high-quality trials. [2] Because no mold-specific peer-reviewed index paper was supplied, there is no direct evidence here supporting a strong mold-toxicity claim.
- Mainstream view
- Mainstream medicine recognizes that damp indoor environments and mold can worsen allergies, asthma, and some respiratory symptoms, and remediation of moisture problems is recommended. Broad claims that mold commonly causes chronic multisystem illness are not supported by strong consensus evidence, especially without a clear exposure history, symptom pattern, and objective findings. [1][2][3][4]
“If you are struggling with mold”
Rule: K.S.A. 65-2912(a)(6) (analogous non-physician limit on treating human ailments except as authorized)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Lyme disease management.
Lyme disease management
- Supports
- Because the influencer’s claim is only the single word “Lyme,” there is no specific, testable assertion (for example, about diagnosis, chronic infection, specific treatments, or vaccines). However, there is strong high‑quality evidence and major guidelines describing Lyme disease as a well‑characterized tick‑borne bacterial infection, its diagnostic approach, and short‑course antibiotic treatment as effective for typical disease. Multiple evidence‑based guidelines (IDSA/AAN/ACR 2020, national guideline summaries) endorse: (1) clinical diagnosis and prompt antibiotic therapy for typical erythema migrans without needing laboratory confirmation; (2) two‑tier serologic testing (screening EIA followed by confirmatory immunoblot) as the standard laboratory method for most other presentations; and (3) defined, relatively short courses of antibiotics (generally 10–28 days) depending on the clinical manifestation, with no evidence that longer courses improve outcomes.[1][2][8][11][16][18] High‑quality European guidelines for neuroborreliosis similarly support that early neuroborreliosis is effectively treated with a 14‑day antibiotic course and that combination or prolonged antibiotic regimens lack valid supporting data.[5] Recent PTLDS guidelines and systematic reviews conclude that in patients with persistent symptoms after appropriate Lyme treatment, additional prolonged or repeated antibiotic courses do not improve quality of life, fatigue, depression, or cognition and are therefore not recommended.[4][5] Major public health authorities and guideline panels (e.g., CDC, IDSA, NICE/NCBI Bookshelf) consistently state that Lyme disease is a recognized infectious disease caused by Borrelia species, primarily transmitted by Ixodes ticks, and that timely, guideline‑based antibiotic therapy is effective for the majority of patients.[7][8][11][18]
- Contradicts
- Because the influencer’s claim is not specific, areas of contradiction or weak evidence mainly concern common controversial narratives about “chronic Lyme” or indefinite antibiotic therapy rather than the existence of Lyme disease itself. High‑quality guidelines and systematic reviews explicitly report that prolonged or repeated antibiotic courses beyond standard durations for post‑treatment persistent symptoms (PTLDS) do not show clinically meaningful benefit in randomized trials or systematic evaluations, and therefore such practices are not recommended.[4][5][17] European neuroborreliosis guidelines note that there are no valid study data supporting combination antibiotic treatments or extended regimens beyond guideline‑specified durations.[5] PTLDS guidance likewise concludes that persistent symptoms after adequate treatment are not attributable to ongoing active infection and that management should focus on multidisciplinary supportive care rather than further antibiotics.[4][5] Major guidelines also emphasize that many patients labeled with “chronic Lyme” lack objective evidence of prior Lyme infection and that Lyme disease is the correct diagnosis for only a minority of patients in whom it is suspected, highlighting diagnostic over‑attribution in some clinical and influencer narratives.[15] In addition, authoritative sources advise against unvalidated diagnostic methods (e.g., nonstandard serologic assays, urine antigen tests, tick testing) and against assuming Lyme disease in the face of negative, properly performed serologic testing with long‑standing symptoms, which contradicts claims that standard tests are broadly unreliable and that Lyme is almost always occult.[8][13][18]
- Mainstream view
- Mainstream medical and scientific consensus is that Lyme disease is a well‑defined zoonotic infection caused by Borrelia burgdorferi sensu lato (and related species), transmitted primarily by Ixodes ticks, with characteristic early manifestations (particularly erythema migrans) and well‑described neurologic, cardiac, and rheumatologic complications in some patients.[1][9][11][18] Diagnosis is based on clinical assessment plus epidemiologic exposure (especially for erythema migrans) and standardized two‑tier serologic testing for most other presentations, using validated assays and interpretive criteria.[8][11][18] Treatment consists of appropriately selected antibiotics (such as doxycycline, amoxicillin, cefuroxime, or IV ceftriaxone) for defined durations typically between 10 and 28 days, tailored to the specific syndrome (early localized disease, neuroborreliosis, arthritis, etc.), with strong evidence that these regimens are generally effective and that longer or repeated courses do not confer additional benefit.[1][5][6][16][18] Persistent or nonspecific symptoms after adequate treatment (PTLDS) are recognized but are not attributed to ongoing active infection; management focuses on rehabilitation and symptom‑directed, multidisciplinary care rather than further antibiotics.[4][5] Major guidelines and public health agencies do not support the concept of “chronic Lyme Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“If you are struggling with mold, Lyme, long COVID, autoimmunity, or any neurodegenerative disorder”
Rule: K.S.A. 65-2912(a)(6); Attorney General Opinion 1987-042 (physician definition for medical and surgical practice)[2][3]
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure long COVID management.
long COVID management
- Supports
- The general claim that long COVID exists as a clinically recognized condition is strongly supported by multiple systematic reviews, meta-analyses and major guidelines from 2021–2026. Long COVID (also called post‑acute sequelae of SARS‑CoV‑2 infection, post‑COVID‑19 condition, or post‑COVID syndrome) is consistently described as persistent, relapsing, or newly developed symptoms following SARS‑CoV‑2 infection that last beyond the acute phase, typically at least 4 weeks and more often 3 months or longer. Multiple systematic reviews and meta-analyses document substantial global prevalence of persistent symptoms after COVID-19, often in the range of roughly 20–40% depending on definition, population, and follow‑up duration, supporting that long COVID represents a major post‑acute public health burden. [11] A comprehensive systematic scoping review of long COVID literature reports that many studies describe persistent fatigue, breathlessness, arthralgia, sleep difficulties, chest pain, and other multi‑system symptoms long after acute infection, including cutaneous, respiratory, cardiovascular, musculoskeletal, neurologic, mental health, and renal involvement, which supports the existence of a long‑term sequelae syndrome. [10] Living and conventional systematic reviews characterising long COVID conclude that it is a heterogeneous condition affecting both previously hospitalized and non‑hospitalized people, with prolonged fatigue, weakness, malaise, breathlessness, and concentration impairment lasting weeks to months. [12] A large systematic review and meta-analysis of post‑COVID syndrome prevalence defines post‑COVID syndrome as signs and symptoms developing during or after infection, continuing beyond 12 weeks and not explained by another diagnosis, and finds non‑trivial prevalence, reinforcing recognition of long COVID as a chronic sequela. [9] Similarly, systematic reviews of post‑acute sequelae in hospitalized patients, and of long-term sequelae over multi‑year follow‑up, confirm that many individuals experience persistent symptoms and organ-specific complications well beyond the initial illness, again supporting the reality of long COVID. High‑level guidance bodies explicitly define long COVID/post‑COVID condition. The World Health Organization consensus definition describes post‑COVID‑19 condition as continuation or development of new symptoms three months after initial infection, lasting at least two months and not explained by an alternative diagnosis, demonstrating formal international recognition. This definition is echoed and operationalized within recent global prevalence reviews. The UK’s NICE guidance and related patient‑facing summaries advise clinicians to consider long COVID when symptoms develop during or after COVID‑19 and continue for more than 12 weeks without an alternative explanation, operationalizing the concept into clinical practice. The National Academies of Sciences, Engineering and Medicine (NASEM) 2024 report similarly defines long COVID as an infection‑associated chronic condition after SARS‑CoV‑2 infection, present for at least three months, with continuous, relapsing‑remitting, or progressive disease affecting one or more organ systems, reinforcing its status as a recognized chronic disease state. Systematic reviews also support specific long COVID manifestations, such as pain syndromes and sleep disturbances. Meta‑analyses of long‑term post‑acute sequelae related to pain document that a subset of patients suffer pain and other symptoms for more than one month after initial onset or hospital discharge, fitting long COVID definitions. A global systematic review and meta‑analysis of long COVID insomnia and randomized controlled trial meta‑analyses of interventions for sleep disturbances in long COVID patients further support that sleep-related symptoms are common and clinically significant components of long COVID, and that targeted management strategies are being studied. Additionally, systematic reviews of specific post‑COVID conditions such as postural orthostatic tachycardia syndrome (POTS) show that dysautonomia syndromes can occur following COVID-19 as part of long COVID and often require pharmacologic treatment, again underscoring the clinical reality of long‑term sequelae. Overall, high‑quality evidence from systematic reviews, meta‑analyses and major guidelines strongly supports the existence of long COVID as a clinically important, heterogeneous, and sometimes chronic sequela of SARS‑CoV‑2 infection, with multi‑system manifestations and substantial prevalence, even though case definitions and exact prevalence estimates vary.
“If you are struggling with mold, Lyme, long COVID, autoimmunity, or any neurodegenerative disorder”
Rule: K.S.A. 65-2912(a)(6) (analogous non-physician scope limit)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure autoimmunity management.
autoimmunity management
- Supports
- The influencer’s claim is just the single word “autoimmunity,” with no explicit proposition (for example, that autoimmunity is always harmful, always curable, caused only by diet, etc. [22][23][24] ), so there is no specific claim that can be directly supported by the listed index papers. The index papers provided relate to hypertension management , clinical nutrition and parenteral/enteral feeding , nutrition in inflammatory bowel disease (which can include autoimmune forms of IBD) , methods for rating evidence quality , and several unrelated clinical trials on DNA sequencing in practice, analgesia, wound healing, and infectious disease treatment . [1][2][3][20] None of these papers present a core definitional or mechanistic claim about autoimmunity itself that would allow a direct “support” of any particular influencer assertion about autoimmunity. They show only that autoimmune phenomena may be relevant in specific diseases such as inflammatory bowel disease and AIDS-related infections, and that evidence grading and guideline-driven care are used in clinical research and practice, but they do not substantiate any standalone influencer claim about autoimmunity. [21]
- Contradicts
- Because the influencer’s claim is not specified beyond the word “autoimmunity,” there is no concrete proposition (for example, that autoimmunity is purely a lifestyle choice, universally reversible, or always misdiagnosed) that can be compared against the index papers. [22][23][24] The guideline-driven hypertension management paper focuses on cardiovascular risk factors and pharmacologic/nonpharmacologic blood pressure control, not on autoimmunity, and would contradict any implication that hypertension treatment is primarily an autoimmune issue. [1] The ASPEN-FELANPE and ESPEN nutrition guidelines focus on evidence-based nutrition care in critical illness and inflammatory bowel disease and do not assert that autoimmunity is the root cause of all disease or that simple nutritional changes universally cure autoimmune conditions. [2][3][21] The GRADE methodology paper demonstrates that mainstream medicine requires high-quality, precise evidence before strong clinical claims are accepted, which would contradict any sweeping, unqualified influencer statements about autoimmunity that lack such supporting data. [20] The remaining clinical trials (DNA sequencing in practice, tizanidine as an analgesic adjunct, platelet-rich fibrin for mucosal healing, and cryptosporidiosis treatment in AIDS) focus on distinct clinical problems and do not support extreme, generalized claims about autoimmunity as their unifying mechanism or cure.
- Mainstream view
- Mainstream medical and scientific positions hold that autoimmunity refers to immune responses directed against self-antigens, leading to a wide spectrum of autoimmune diseases, many of which are chronic and require long-term management rather than simple cures. [21][22][24] Autoimmunity is understood as multifactorial, involving genetic predisposition, immune regulation, environmental triggers, and in some cases nutritional status or gut-related factors, but it is not considered the single cause of all disease. Major guidelines in other areas, such as hypertension and clinical nutrition, illustrate that mainstream medicine treats autoimmunity as one among many important mechanisms in human disease, and uses structured frameworks like GRADE to evaluate evidence before adopting management strategies. [1][2][3][20][23] Inflammatory bowel disease guidelines, for example, acknowledge immune-mediated and inflammatory mechanisms but still emphasize a comprehensive approach combining pharmacologic, nutritional, and sometimes surgical management, rather than framing autoimmunity alone as the entire explanation or an easily reversible process. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“If you are struggling with mold, Lyme, long COVID, autoimmunity, or any neurodegenerative disorder”
Rule: K.S.A. 65-2912(a)(6); AG Opinion defining physician for medical practice[2][3]
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure mold.
mold
- Supports
- No high-quality evidence in the provided index papers supports the standalone claim “mold” as a medical assertion. The listed peer-reviewed papers are unrelated guideline articles on hypertension, nutrition, and inflammatory bowel disease, so they do not provide supportive evidence for a general claim about mold exposure or mold illness . [1][3][4]
- Contradicts
- The claim is too vague to evaluate as written, and the provided index papers do not address mold at all; therefore they neither support nor meaningfully test it . In mainstream medical literature, indoor dampness and visible mold are associated with respiratory symptoms and asthma exacerbation, but broad claims that mold causes nonspecific systemic illness in most people are not established by major guidelines or high-quality trials. [2] Because no mold-specific peer-reviewed index paper was supplied, there is no direct evidence here supporting a strong mold-toxicity claim.
- Mainstream view
- Mainstream medicine recognizes that damp indoor environments and mold can worsen allergies, asthma, and some respiratory symptoms, and remediation of moisture problems is recommended. Broad claims that mold commonly causes chronic multisystem illness are not supported by strong consensus evidence, especially without a clear exposure history, symptom pattern, and objective findings. [1][2][3][4]
“If you are struggling with mold”
Rule: K.S.A. 65-2912(a)(6) (analogous limit)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure neurodegenerative disorder.
neurodegenerative disorder
No specific health claims of theirs were cross-checked against the literature.
“If you are struggling with mold, Lyme, long COVID, autoimmunity, or any neurodegenerative disorder”
Rule: K.S.A. 65-2912(a)(6); AG Opinion defining physician for medical practice[2][3]
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure integrated approach.
integrated approach
No specific health claims of theirs were cross-checked against the literature.
“looking for an integrated approach”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure free discovery call.
free discovery call
No specific health claims of theirs were cross-checked against the literature.
“feel free to schedule a free discovery call to see if we can help”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise telehealth across the country as within their scope of practice.
telehealth across the country
No specific health claims of theirs were cross-checked against the literature.
“We offer telehealth across the country”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure neurodegenerative disorder management.
neurodegenerative disorder management
No specific health claims of theirs were cross-checked against the literature.
“If you are struggling with mold, Lyme, long COVID, autoimmunity, or any neurodegenerative disorder”
Rule: K.S.A. 65-2912(a)(6); AG Opinion 1987-042 on physician practice[2][3]
Manipulation
transcript · cited
This is a classic top-of-funnel booking CTA. It turns fear about complex chronic illness into a lead capture event, likely before any clear diagnosis or treatment rationale is disclosed. Likely motive: Convert distressed viewers into consult bookings and downstream paid care
“feel free to schedule a free discovery call to see if we can help”
transcript · cited
The post stacks multiple scary, hard-to-treat conditions together to maximize anxiety and perceived need for specialized help. That makes the clinic look like a catch-all solution for complex disease. Likely motive: Inflate urgency and make the clinic seem uniquely capable of handling severe illness
“mold, Lyme, long COVID, autoimmunity, or any neurodegenerative disorder”
transcript · cited
The post borrows legitimacy from an external ranking without explaining the methodology, who paid for placement, or whether the ranking is editorial, sponsored, or pay-to-play. Likely motive: Borrow credibility to reduce skepticism and increase appointment conversions
“just got rated as one of the best clinics for chronic health conditions”
transcript · cited
This expands the potential customer pool far beyond local patients and signals a scalable intake funnel for chronic-illness consultations. Likely motive: Broaden lead generation and book more paid visits
“We offer telehealth across the country”
Commerce & grift map
The likely flow is attention from scary chronic-illness framing into a free discovery call, then into paid consults or a membership-style care plan. The post does not show supplements or lab panels directly, but it clearly uses a ranking badge plus broad disease labels to seed the sales funnel.
No FTC-style compensation disclosure
compensationDisclosures · scan
Free discovery call used as lead capture for clinic services and likely downstream paid care.
coaching_program
Host self-funnel around guest content
guestCollaboration · selfFunnel
Host routes viewers to their own consult/booking links around the guest segment.
How the money flows
- Coaching or consult upsellUndisclosed Free discovery call used as lead capture for clinic services and likely downstream paid care. “schedule a free discovery call to see if we can help”
“schedule a free discovery call to see if we can help”
Credentials & scope
Glossary: Chiropractor (“Dr.”)
Stated: none · Likely: Chiropractor
Verified against the federal provider registry: D.C. · Chiropractor · KS license 0105307.
The post uses the Jonah Yakel title, but this clip does not state the underlying license or specialty. On this surface, the bigger issue is the clinic marketing broad chronic-disease management claims rather than any explicit credential inflation.
- Chiropractor (DC), Doctor of Chiropractic
Kansas DCs are regulated by the Kansas State Board of Healing Arts. Scope is limited to chiropractic methods for musculoskeletal and nervous-system conditions, not general internal medicine, hormone replacement medicine, or primary disease management.
Permitted scope vs advertised
Kansas State Board of Healing Arts (Chiropractic) · Confidence: low
Kansas chiropractors are authorized to examine, diagnose, and treat patients by means of chiropractic procedures directed at the spine and related structures; they are not affirmatively authorized to diagnose or manage systemic infectious, autoimmune, or neurodegenerative diseases or to provide primary medical care. Kansas scope rules for non-physician licensees require that any treatment of human ailments be within the specific methods and conditions authorized by statute and board regulation.[3]
What this license permits
- Spinal adjustment and manipulation
- Musculoskeletal evaluation and treatment
- Soft-tissue and rehabilitative care
- Headache care within musculoskeletal scope
13 of 13 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| Listed service Lyme Rule: K.S.A. 65-2912(a)(6) (used by analogy for non-physician licensees under KSBHA) Diagnosing Lyme disease is diagnosis of a systemic infectious disease, which is not affirmatively authorized as part of Kansas chiropractic scope and mirrors other non-physician scope provisions that restrict treatment of human ailments to the methods authorized by their specific practice acts.[3] | Outside scope |
| Listed service long COVID Rule: K.S.A. 65-2912(a)(6) (analogous scope limit) Diagnosing long COVID involves assessing multisystem post-viral complications, which falls into systemic medical disease management and is not affirmatively included in Kansas chiropractic scope.[3] | Outside scope |
| Listed service autoimmunity Rule: K.S.A. 65-2912(a)(6) (analogous scope limit on treating ailments outside the act) Diagnosing autoimmune disease concerns systemic immunologic disorders, which are not affirmatively permitted for chiropractors under Kansas board-governed scopes that confine non-physician practice to their defined therapeutic methods.[3] | Outside scope |
| chronic mold illness management Rule: K.S.A. 65-2912(a)(6) (analogous non-physician limit on treating human ailments except as authorized) Managing chronic mold-related illness implies ongoing medical management of a systemic toxic or allergic condition, which is beyond the affirmative chiropractic authority focused on musculoskeletal care and not authorized as a treatment method in Kansas statutes.[3] | Outside scope |
| Lyme disease management Rule: K.S.A. 65-2912(a)(6); Attorney General Opinion 1987-042 (physician definition for medical and surgical practice)[2][3] Lyme disease management denotes ongoing medical treatment of a systemic infectious disease, which is not affirmatively within Kansas chiropractic therapeutic methods and resembles primary medical care reserved to physicians.[2][3] | Outside scope |
| long COVID management Rule: K.S.A. 65-2912(a)(6) (analogous non-physician scope limit) Long COVID management entails multisystem medical management and rehabilitation of post-viral sequelae, which goes beyond chiropractic spinal-focused procedures and is not affirmatively authorized under Kansas non-physician scope provisions.[3] | Outside scope |
| autoimmunity management Rule: K.S.A. 65-2912(a)(6); AG Opinion defining physician for medical practice[2][3] Managing autoimmunity implies directing systemic immune-modulating care and disease management, which is characteristic of medical practice and not affirmatively allowed within Kansas chiropractic scope.[2][3] | Outside scope |
| Listed service mold Rule: K.S.A. 65-2912(a)(6) (analogous limit) Diagnosing mold-related illness or toxicity concerns systemic allergic or toxic conditions, which are not specifically or affirmatively permitted as chiropractic diagnoses under Kansas board-governed non-physician scopes.[3] | Outside scope |
| Listed service neurodegenerative disorder Rule: K.S.A. 65-2912(a)(6); AG Opinion defining physician for medical practice[2][3] Diagnosing neurodegenerative disorders such as Parkinson’s or Alzheimer’s involves complex CNS disease diagnosis that falls under medical neurology and is not affirmatively described as part of chiropractic scope in Kansas.[2][3] | Outside scope |
| Listed service integrated approach Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service free discovery call Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service telehealth across the country Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| neurodegenerative disorder management Rule: K.S.A. 65-2912(a)(6); AG Opinion 1987-042 on physician practice[2][3] Managing neurodegenerative disorders implies ongoing medical treatment and care planning for serious CNS diseases, which is characteristic of physician neurologic practice and is not affirmatively within Kansas chiropractic therapeutic authority.[2][3] | Outside scope |
Sources: Kansas State Board of Healing Arts – Agency site (official), Kansas Statutes, ch. 65-2912 (illustrative scope control for non-physician licensees under KSBHA) (official), Kansas State Board of Healing Arts – Stats and Regs portal, Kansas State Board of Healing Arts
Validated associated properties
Surfaces tied to this Doc Bro by domain, branding, or funnel routing. Third-party platforms are labeled as routes, not as owned properties.
Analyzed
- OwnedOfficial site (drjonahyakel.com)
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission MvLZFLt0vStCROCW2kndp
Fight disinformation
Log a public thread where Jonah Dallas Yakel is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked Jonah Dallas Yakel's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/MvLZFLt0vStCROCW2kndp. White-coat charisma isn't evidence.
Full DTMB scan on Jonah Dallas Yakel: https://drtrustmebro.com/analyze/MvLZFLt0vStCROCW2kndp
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
No conversation links logged yet. Be the first above.
Nudge the Doc Bro
We email a public contact address from their site so Jonah Dallas Yakel can review this dossier and dispute anything we got wrong.
Know someone who can help?
If you think someone has firsthand information about Jonah Dallas Yakel, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for Jonah Dallas Yakel. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: 0o8IxZAbZXTO291VUoiW9
- Wall entry: /influencer/0o8IxZAbZXTO291VUoiW9
- Analysis ID: MvLZFLt0vStCROCW2kndp
- Source: https://www.facebook.com/drjonahyakel/posts/pfbid02yGTUrwWz8bi1s56k16Lz7fUYMczaVboxMh4Edh7KiFm5N7mr5h3BNXeraGJUCtjjl
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] Guideline-Driven Management of Hypertension: An Evidence-Based Update.
- [2] ASPEN-FELANPE Clinical Guidelines.
- [3] ESPEN guideline: Clinical nutrition in inflammatory bowel disease.
- [4] When Is Parenteral Nutrition Appropriate?
- [5] Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease.
- [6] Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease
- [7] Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease
- [8] Clinical Care of Lyme Disease
- [9] A systematic review and meta-analysis of long COVID ...
- [10] Long COVID, a comprehensive systematic scoping review - PMC
- [11] Systematic Review of the Prevalence of Long COVID
- [12] Characterising long COVID: a living systematic review - PMC
- [13] PubMed indexed study
- [14] PubMed indexed study
- [15] PubMed indexed study
- [16] PubMed indexed study
- [17] PubMed indexed study
- [18] PubMed indexed study
- [19] PubMed indexed study
- [20] GRADE guidelines 6. Rating the quality of evidence--imprecision.
- [21] Definition of Autoimmunity & Autoimmune Disease
- [22] Biochemistry, Autoimmunity - StatPearls - NCBI Bookshelf - NIH
- [23] Understanding Autoimmunity: Mechanisms, Predisposing ...
- [24] Autoimmunity - an overview